Last update 01 Nov 2024

Alter Ltd.

Private Company|
Poland
|
www.alter.org

Overview

Related

5
Drugs associated with Alter Ltd.
Furaldipine
Target
L-type calcium channel
Mechanism
L-type calcium channel blockers
Active Org.-
Originator Org.
Dr. Willmar Schwabe GmbH & Co. KGDr. Willmar Schwabe GmbH & Co. KG
Active Indication-
Inactive Indication
Heart Failure [+2]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Cercainide
Target
SCNA
Mechanism
SCNA blockers
Active Org.-
Originator Org.
Alter Ltd.
Active Indication-
Inactive Indication
Arrhythmias, Cardiac
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
PCA-50982
Target
VDCCs
Mechanism
VDCCs blockers
Active Org.-
Originator Org.
Alter Ltd.
Active Indication-
Inactive Indication
Angina Pectoris
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Alter Ltd.
Login to view more data
0 Patents (Medical) associated with Alter Ltd.
Login to view more data
100 Deals associated with Alter Ltd.
Login to view more data
100 Translational Medicine associated with Alter Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
5
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Furaldipine
 ( L-type calcium channel )		Myocardial Ischemia
More
Discontinued
Trombodipine
 ( PDE5A )		Myocardial Ischemia
More
Discontinued
Cercainide
 ( SCNA )		Arrhythmias, Cardiac
More
Discontinued
PCA-50982
 ( VDCCs )		Angina Pectoris
More
Discontinued
Tiapafant
 ( PAF receptor )		Shock, Septic
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free